Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576537 · ClinicalTrials.gov registry record · Phase 2
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
A Phase 2 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00576537 is a Phase 2 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT00576537, a Phase 2 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.
Interventions
- BIOLOGICAL Dendritic Cell Immunotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2001-03 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576537
The ClinicalTrials.gov registry entry for NCT00576537 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dendritic Cell Immunotherapy is the first listed.
NCT00576537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576537 about?
NCT00576537 is a clinical study titled "Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors". This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.
What is the current status of trial NCT00576537?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2001-03. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00576537?
The interventions under investigation include: Dendritic Cell Immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT00576537?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.